NCT07073326View on ClinicalTrials.gov

Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

July 31, 2026

Conditions
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNormobaric Hypoxia
Interventions
OTHER

HYPOTRAIN

8 weeks of 2/3 times per week, 1-h aerobic training (walking on a treadmill at 60-65% HRmax) while wearing a mask and air is delivered between 15 and 16 FiO2%

OTHER

NORMOTRAIN

8 weeks of 2/3 times per week, 1-h aerobic training (walking on a treadmill at 60-65% HRmax) while wearing a mask and air is delivered between at normal (around 21) FiO2%

All Listed Sponsors
lead

University of Trieste

OTHER

NCT07073326 - Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Biotech Hunter | Biotech Hunter